# Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer

> **NCT00055822** · PHASE1,PHASE2 · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 16 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **BIOLOGICAL:** oblimersen sodium
- **DRUG:** fluorouracil
- **DRUG:** leucovorin calcium
- **DRUG:** oxaliplatin

## Key facts

- **NCT ID:** NCT00055822
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2004-10
- **Final completion:** 2004-10
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2012-07-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00055822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00055822, "Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00055822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*